The Australia Remote Patient Monitoring (RPM) Market was valued at $1010.8 Million in 2026 and projected to reach to $1938.2 Million by 2031, representing a compound annual growth rate of 13.9%. Australia's Remote Patient Monitoring market for neurological conditions is experiencing accelerated growth, driven by an aging population with increasing prevalence of neurological disorders and widespread adoption of digital health technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia's RPM Neurological Monitoring segment is projected to grow from $1,010.8 million in 2026 to $1,938.2 million by 2031, representing a robust 13.9% CAGR, outpacing the global average of 12.8%.
Australian healthcare providers are rapidly integrating RPM solutions for managing epilepsy, Parkinson's disease, and stroke recovery, driven by government digital health initiatives and aging population demographics.
The Australian government's commitment to telehealth reimbursement and digital health infrastructure investments creates a favorable environment for RPM technology deployment across neurological care settings.
Australia's advanced healthcare system, high internet penetration, and strong private health insurance sector position it as a mature market for premium neurological monitoring solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ASIA PACIFIC (Indication) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 12.8% from 2026 to 2031 |
| Largest Segment | DEVICES (Component) |
| Market Size Base Year (Billions) | ~USD 36.32 (2026) |
| Revenue Forecast (Billions) | ~USD 66.33 (2031) |
| Segments Covered | Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type |
8 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| ORACLE | United States | Public Company | Cloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.
Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.
GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.
Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.
Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.
Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.
Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.
Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.
Neurological Monitoring is a Remote Patient Monitoring function that uses connected devices and digital platforms to continuously track neurological conditions such as epilepsy, Parkinson's disease, and stroke recovery in real-time.
Neurological Monitoring is estimated at $1,010.8 million in 2026, representing a significant functional segment within the broader Remote Patient Monitoring market.
Neurological Monitoring is forecast to reach $1,938.2 million by 2031, reflecting a compound annual growth rate of 13.9% over the five-year forecast period.
Neurological Monitoring growth is driven by advances in wearable sensors, artificial intelligence analytics, cloud-based data platforms, and integration with electronic health records systems.
Neurological Monitoring is particularly effective for managing epilepsy, Parkinson's disease, multiple sclerosis, stroke recovery, and other chronic neurological conditions requiring continuous oversight.
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report